SK286427B6 - Polymorfná forma soli 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu s kyselinou maleínovu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie - Google Patents

Polymorfná forma soli 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu s kyselinou maleínovu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie Download PDF

Info

Publication number
SK286427B6
SK286427B6 SK1492-2001A SK14922001A SK286427B6 SK 286427 B6 SK286427 B6 SK 286427B6 SK 14922001 A SK14922001 A SK 14922001A SK 286427 B6 SK286427 B6 SK 286427B6
Authority
SK
Slovakia
Prior art keywords
polymorph
pyridyl
ethoxy
benzyl
methyl
Prior art date
Application number
SK1492-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK14922001A3 (sk
Inventor
Paul David James Blackler
Christine Marie Browne
Timothy G. Coakley
Robert Gordon Giles
Gillian Morrissey
Original Assignee
Smithkline Beecham Plc
Smithkline Beecham (Cork) Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26315461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK286427(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9909473.2A external-priority patent/GB9909473D0/en
Priority claimed from GBGB9912196.4A external-priority patent/GB9912196D0/en
Application filed by Smithkline Beecham Plc, Smithkline Beecham (Cork) Limited filed Critical Smithkline Beecham Plc
Publication of SK14922001A3 publication Critical patent/SK14922001A3/sk
Publication of SK286427B6 publication Critical patent/SK286427B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1492-2001A 1999-04-23 2000-04-19 Polymorfná forma soli 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu s kyselinou maleínovu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie SK286427B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9909473.2A GB9909473D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9912196.4A GB9912196D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical
PCT/GB2000/001520 WO2000064896A1 (en) 1999-04-23 2000-04-19 Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt

Publications (2)

Publication Number Publication Date
SK14922001A3 SK14922001A3 (sk) 2002-02-05
SK286427B6 true SK286427B6 (sk) 2008-09-05

Family

ID=26315461

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1492-2001A SK286427B6 (sk) 1999-04-23 2000-04-19 Polymorfná forma soli 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu s kyselinou maleínovu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie

Country Status (40)

Country Link
US (2) US6806280B1 (ko)
EP (2) EP1304330A3 (ko)
JP (1) JP2002543077A (ko)
KR (1) KR100744360B1 (ko)
CN (1) CN1167702C (ko)
AP (1) AP1598A (ko)
AR (2) AR023561A1 (ko)
AT (1) ATE246191T1 (ko)
AU (1) AU765005B2 (ko)
BG (1) BG65485B1 (ko)
BR (1) BR0009932A (ko)
CA (1) CA2370280A1 (ko)
CO (1) CO5170421A1 (ko)
CZ (1) CZ20013800A3 (ko)
DE (1) DE60004196T2 (ko)
DK (1) DK1173435T3 (ko)
DZ (1) DZ3156A1 (ko)
EA (1) EA004541B1 (ko)
ES (1) ES2203453T3 (ko)
HK (1) HK1045153B (ko)
HR (1) HRP20010772B1 (ko)
HU (1) HUP0200931A3 (ko)
IL (1) IL146111A0 (ko)
MA (1) MA25356A1 (ko)
MX (1) MXPA01010821A (ko)
MY (1) MY131973A (ko)
NO (1) NO320574B1 (ko)
NZ (1) NZ515168A (ko)
OA (1) OA11872A (ko)
PE (1) PE20010044A1 (ko)
PL (1) PL351684A1 (ko)
PT (1) PT1173435E (ko)
SK (1) SK286427B6 (ko)
TR (1) TR200103062T2 (ko)
TW (1) TWI283677B (ko)
UA (1) UA67844C2 (ko)
UY (1) UY26121A1 (ko)
WO (1) WO2000064896A1 (ko)
YU (1) YU75301A (ko)
ZA (1) ZA200108719B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US20020137940A1 (en) * 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US20040248945A1 (en) 1999-04-23 2004-12-09 Smithkline Beecham P.L.C. Thiazolidinedione derivative and its use as antidiabetic
ES2203453T3 (es) * 1999-04-23 2004-04-16 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bentil)tiazolidina-2,4-diona.
OA11871A (en) 1999-04-23 2006-03-27 Smithkline Beecham Plc Novel pharmaceutical.
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
US7241895B2 (en) 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
EP1322647A1 (en) * 2000-09-26 2003-07-02 Dr. Reddy's Research Foundation Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt and process for their preparation
SK288052B6 (sk) * 2002-04-19 2013-03-01 Faes Farma, S.A. Polymorph 1 of bilastine, process for preparing thereof, its antihistaminic and antiallergic use and pharmaceutical preparation containing it
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
EP1709038A2 (en) * 2004-01-28 2006-10-11 Usv Limited A process for the preparation of 5- 4- 2- n-methyl -n-(2-pyridyl) amino ethoxy phenyl methyl thiaz olidine-2, 4-dione maleate
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
US20090076093A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched rosiglitazone
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate
JP2010013472A (ja) * 2009-09-09 2010-01-21 Faes Farma Sa ４−［２−［１−（２−エトキシエチル）−１Ｈ−ベンズイミダゾール−２−イル］−１−ピペリジニル］エチル］−α，α−ジメチルベンゼノ酢酸の多形体
JOP20190144A1 (ar) 2016-12-16 2019-06-16 Janssen Pharmaceutica Nv إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز
TW202016110A (zh) 2018-06-15 2020-05-01 比利時商健生藥品公司 Ｊａｋ激酶家族之小分子抑制劑

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US6462337B1 (en) * 2000-04-20 2002-10-08 Agilent Technologies, Inc. Mass spectrometer electrospray ionization
GB9124513D0 (en) 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
DE4404198A1 (de) 1994-02-10 1995-08-17 Henkel Kgaa 2-Fluor-6-nitroaniline
UY24886A1 (es) * 1997-02-18 2001-08-27 Smithkline Beecham Plc Tiazolidindiona
US6632947B2 (en) * 1997-02-18 2003-10-14 Smithkline Beecham Plc Process for the preparation of substituted thiazolidinedione
GB9711683D0 (en) * 1997-06-05 1997-08-06 Smithkline Beecham Plc Composition
US7091359B2 (en) * 1997-11-04 2006-08-15 Smithkline Beecham Plc Process for the preparation of thiazolidinedione derivatives
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
US6613785B2 (en) * 1998-07-21 2003-09-02 Smithkline Beecham Plc Use of glucose uptake enhancer for reducing post-ischemic injury of the heart
OA11871A (en) 1999-04-23 2006-03-27 Smithkline Beecham Plc Novel pharmaceutical.
PE20010045A1 (es) 1999-04-23 2001-03-10 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona
ES2203453T3 (es) * 1999-04-23 2004-04-16 Smithkline Beecham Plc Polimorfo de sal del acido maleico de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bentil)tiazolidina-2,4-diona.
CN1277965A (zh) 2000-06-14 2000-12-27 中国医药研究开发中心 盐酸罗格列酮及其应用
EP1322647A1 (en) 2000-09-26 2003-07-02 Dr. Reddy's Research Foundation Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt and process for their preparation

Also Published As

Publication number Publication date
ZA200108719B (en) 2002-06-21
HUP0200931A3 (en) 2004-03-29
DK1173435T3 (da) 2003-11-24
AP1598A (en) 2006-04-26
NZ515168A (en) 2004-02-27
DZ3156A1 (fr) 2000-11-02
EP1304330A3 (en) 2003-11-19
HK1045153B (zh) 2004-07-09
US6806280B1 (en) 2004-10-19
BR0009932A (pt) 2002-04-09
HRP20010772B1 (en) 2007-05-31
TR200103062T2 (tr) 2002-05-21
DE60004196T2 (de) 2004-04-15
SK14922001A3 (sk) 2002-02-05
CZ20013800A3 (cs) 2002-04-17
NO320574B1 (no) 2005-12-27
AU4130800A (en) 2000-11-10
MA25356A1 (fr) 2001-12-31
EA004541B1 (ru) 2004-06-24
MY131973A (en) 2007-09-28
MXPA01010821A (es) 2003-09-04
KR20010110797A (ko) 2001-12-13
NO20015147L (no) 2001-12-17
AU765005B2 (en) 2003-09-04
PL351684A1 (en) 2003-06-02
BG106121A (en) 2002-05-31
PT1173435E (pt) 2003-12-31
OA11872A (en) 2006-03-27
WO2000064896A9 (en) 2001-10-25
CN1356999A (zh) 2002-07-03
EA200101121A1 (ru) 2002-04-25
YU75301A (sh) 2004-07-15
ES2203453T3 (es) 2004-04-16
JP2002543077A (ja) 2002-12-17
HK1045153A1 (en) 2002-11-15
AP2001002330A0 (en) 2000-12-31
DE60004196D1 (de) 2003-09-04
AR023565A1 (es) 2002-09-04
BG65485B1 (bg) 2008-09-30
CA2370280A1 (en) 2000-11-02
HUP0200931A2 (en) 2002-08-28
WO2000064896A1 (en) 2000-11-02
US20050080114A1 (en) 2005-04-14
IL146111A0 (en) 2002-07-25
CN1167702C (zh) 2004-09-22
KR100744360B1 (ko) 2007-07-30
ATE246191T1 (de) 2003-08-15
EP1304330A2 (en) 2003-04-23
AR023561A1 (es) 2002-09-04
EP1173435A1 (en) 2002-01-23
HRP20010772A2 (en) 2002-10-31
UA67844C2 (uk) 2004-07-15
PE20010044A1 (es) 2001-03-10
NO20015147D0 (no) 2001-10-22
EP1173435B1 (en) 2003-07-30
TWI283677B (en) 2007-07-11
CO5170421A1 (es) 2002-06-27
UY26121A1 (es) 2000-12-29

Similar Documents

Publication Publication Date Title
SK286427B6 (sk) Polymorfná forma soli 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu s kyselinou maleínovu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
US6815457B1 (en) Thiazolidinedione derivative and its use as antidiabetic
SK14932001A3 (sk) Polymorfná forma 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoxy] benzyl]tiazolidín-2,4-diónu s kyselinou maleínovou, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
US7358366B2 (en) Thiazolidinedione derivative and its use as antidiabetic
SK14902001A3 (sk) Dihydrát hydrochloridu 5-[4-[2-(N-metyl-(2-pyridyl)amino)etoxy] benzyl]tiazolidín-2,4-diónu, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie
ZA200108722B (en) Thiazolidinedione derivative and its use as antidiabetic.

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20090419